N-Acetyl Selank Amidate Spray — Research Grade Neuropeptide
N-Acetyl Selank Amidate is a modified form of Selank, a synthetic heptapeptide analogue of the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg), developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. The N-acetyl and amidate modifications significantly enhance stability and resistance to enzymatic degradation compared to unmodified Selank, extending its effective duration in biological systems and increasing its potency in research models. This spray formulation provides research-grade N-Acetyl Selank Amidate at ≥99% purity, suitable for intranasal delivery in research protocols.
Research Background
Selank and its enhanced analogues have been studied primarily for anxiolytic and nootropic effects in preclinical and Russian clinical research. Unlike benzodiazepines, Selank’s anxiolytic activity is proposed to occur through modulation of GABA-A receptor expression, BDNF upregulation, and serotonin/dopamine metabolism normalization — without the sedation, tolerance, or withdrawal effects associated with classical anxiolytics. Published studies also document immune-modulatory effects through tuftsin receptor pathways, connecting Selank to both neurological and immunological research applications.
Compound Specifications
- Format: Nasal spray solution
- Purity: ≥99% (HPLC verified)
- Active compound: N-Acetyl Selank Amidate
- Storage: 2–8°C refrigerated, protected from light
- Base peptide sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selank)
Certificate of Analysis
All N-Acetyl Selank Amidate spray vials are third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
